silenThunderr

STAR Analysis June 2021

做多
silenThunderr 已更新   
NSE:STAR   STRIDES PHARMA SCI
Sideways Consolidation ongoing
25 Weeks
Stage Formation expecting it to BO upside and convert to Stage 2.

Pharma sector has strength and tailwinds for this stock.

Further Analysis will follow UP.
评论:
Yearly Market Profile Update

评论:
Daily Analysis

评论:
CRS with NIFTY 100 EQ

评论:
CRS with NIFTY PHARMA

评论:
VOL Profile Update

评论:
评论:
CRS

评论:
Very Advanced CRS

评论:
评论:
Currently its taking Support at 200D EMA
评论:
Seems completion of ABC pattern

评论:
Failed due Fundamental Reasons exited

silenThunderr
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。